Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

The Big Bet on Seattle Genetics
Motley Fool
Tuesday, July 12, 2011 - 12:13pm
tags:
Seattle Genetics, brentuximab vedotin, Hodgkin's lymphoma
Bayer Aims To Grow Animal Health Business, R&D Budget
Morningstar, UK
Tuesday, July 12, 2011 - 12:11pm
tags:
Bayer, animal health, R&D
Pharma Execs Confess Innovation Is Lacking
Pharmalot
Tuesday, July 12, 2011 - 12:09pm
tags:
innovation
Exact Sciences' Colon Cancer Screening Trial
TheStreet.com
Tuesday, July 12, 2011 - 12:07pm
tags:
colon cancer, EXACT Sciences, Cologuard
Tarsa gets more financing for oral osteoporosis drug
Bizjournals.com
Tuesday, July 12, 2011 - 12:06pm
tags:
Tarsa, osteoporosis, Calcitonin
Revised rules aim to speed new Alzheimer's drugs
Yahoo/AP
Tuesday, July 12, 2011 - 12:05pm
tags:
Alzheimer's disease, FDA, JNJ, Eli Lilly, Pfizer
More Hot Biotech Trades for Second Half 2011
TheStreet.com
Tuesday, July 12, 2011 - 10:27am
tags:
Targacept, Aveo Pharmaceutical, Threshold Pharmaceuticals, Raptor Pharmaceuticals, Vertex Pharmaceuticals, Soligenix, Spectrum Pharmaceuticals, NuPathe, Pharmasset, Incyte, Adventrx, Celsion, Alimera, GTx, Ariad Pharmaceuticals
Zalicus: A Potential Target for Pfizer
Seeking Alpha
Tuesday, July 12, 2011 - 10:08am
tags:
Zalicus, Pfizer, M&A, Amgen, Covidien, Icagen, Merck, Novartis
Gilead Allows Generic HIV-Drug Sales in Developing Nations
Bloomberg
Tuesday, July 12, 2011 - 10:04am
tags:
HIV, Gilead Sciences, Ranbaxy, generics, Strides Arcolab, Matrixx
Titan Pharma aims to carry Ph3 success to FDA meeting
Fierce Biotech
Monday, July 11, 2011 - 6:55pm
tags:
FDA, Titan, Probuphine
The 15 Most-Watched Biotech Stocks
Motley Fool
Monday, July 11, 2011 - 6:52pm
tags:
biotech, Gilead Sciences, Dendreon, PDL Biopharma, Cell Therapeutics, Amgen, Aeterna Zentaris, Xoma, Geron, Orexigen, Zalicus, Spectrum Pharmaceuticals, Ariad Pharmaceuticals, Biogen Idec, Momenta, StemCells
Forest Labs: 3 Reasons to Finally Be Bullish
Seeking Alpha
Monday, July 11, 2011 - 6:50pm
tags:
Forest Labs
BioSante’s Drug for Women’s Sex Drive Spurs Deal-Making Talks, CEO Says
Bloomberg
Monday, July 11, 2011 - 6:04pm
tags:
BioSante, female sexual dysfunction, Stephen Simes, LibiGel
Abbott Laboratories: Dividend Dynamo or Blowup?
Motley Fool
Monday, July 11, 2011 - 5:02pm
tags:
Abbott Laboratories, dividends
Drug Discounts for Debt Cuts May Lose 260,000 Jobs, Group Says
Bloomberg
Monday, July 11, 2011 - 5:01pm
tags:
layoffs, pharma industry, drug pricing
[video] Eli Lilly: Patents, Pipeline & Growth
CNBC
Monday, July 11, 2011 - 5:00pm
tags:
Eli Lilly, patents, R&D
Merrimack Pharma files for $172.5M IPO
Bizjournals.com
Monday, July 11, 2011 - 4:58pm
tags:
Merrimack Pharmaceuticals, IPOs
Novartis' desire for deals to return soon, CEO says
Fierce Pharma
Monday, July 11, 2011 - 12:52pm
tags:
Novartis, M&A, Joe Jimenez, Pharma CEOs
Bayer's Yasmin to face EU generics this year
Fierce Pharma
Monday, July 11, 2011 - 12:43pm
tags:
Bayer, Europe, generics, Yasmin, birth control pill
PDL climbs 8% on patent case ruling
Marketwatch
Monday, July 11, 2011 - 12:33pm
tags:
PDL Biopharma, patents, Roche, Genentech, Avastin, Herceptin, Lucentis, Xolair

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.